Australian Super Pty LTD Ionis Pharmaceuticals Inc Transaction History

Australian Super Pty LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$47.45 - $62.95 $1.48 Million - $1.97 Million	-31,270 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$46.85 - $61.05 $9,838 - $12,820	210 Added 0.68%	31,270 $1.84 Million
Q1 2020 May 13, 2020	SELL	$41.6 - $63.4 $1.31 Million - $1.99 Million	-31,424 Reduced 50.29%	31,060 $1.47 Million
Q4 2019 Feb 10, 2020	BUY	$53.85 - $65.27 $502,743 - $609,360	9,336 Added 17.57%	62,484 $3.78 Million
Q3 2019 Nov 08, 2019	BUY	$59.06 - $72.15 $3.14 Million - $3.83 Million	53,148 New	53,148 $3.18 Million

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.94B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Australian Super Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Australian Super Pty LTD with notifications on news.